For the tests in human cancer cell lines, we used the MCC14.2 cell line, which is derived from MCC and has strongly reduced expression of ATOH1.
Atoh1 overexpression failed to activate endogenous human ATOH1 expression in the MCC14.2 cell line (Figure 3 C), despite the virtually complete conservation of the two proteins.